Quest Diagnostics Inc
(DGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 175,000 | 315,000 | 700,000 | 790,000 | 712,000 |
| Receivables | 1,254,000 | 1,195,000 | 1,280,000 | 1,293,000 | 1,371,000 |
| Inventories | 190,000 | 192,000 | 183,000 | 187,000 | 197,000 |
| TOTAL | $1,814,000 | $1,898,000 | $2,334,000 | $2,426,000 | $2,475,000 |
| Non-Current Assets | |||||
| PPE Net | 1,795,000 | 1,766,000 | 1,707,000 | 1,664,000 | 1,668,000 |
| Investments And Advances | 128,000 | 132,000 | 138,000 | 147,000 | 155,000 |
| Intangibles | 8,318,000 | 8,312,000 | 8,305,000 | 8,339,000 | 8,369,000 |
| Other Non-Current Assets | 739,000 | 729,000 | 739,000 | 736,000 | 775,000 |
| TOTAL | $10,980,000 | $10,939,000 | $10,889,000 | $10,886,000 | $10,967,000 |
| Total Assets | $12,794,000 | $12,837,000 | $13,223,000 | $13,312,000 | $13,442,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Accounts payable and accrued liabilities | 1,198,000 | 1,396,000 | 1,447,000 | 1,420,000 | 1,544,000 |
| TOTAL | $1,355,000 | $1,551,000 | $1,602,000 | $1,577,000 | $1,700,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,975,000 | 3,978,000 | 3,980,000 | 3,983,000 | 3,985,000 |
| Other Non-Current Liabilities | 1,361,000 | 1,363,000 | 1,349,000 | 1,286,000 | 1,324,000 |
| TOTAL | $5,351,000 | $5,356,000 | $5,349,000 | $5,285,000 | $5,327,000 |
| Total Liabilities | $6,706,000 | $6,907,000 | $6,951,000 | $6,862,000 | $7,027,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 112,009 | 111,323 | 113,888 | 116,606 | 117,365 |
| Common Shares | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Retained earnings | 8,412,000 | 8,290,000 | 8,263,000 | 8,083,000 | 7,926,000 |
| Other shareholders' equity | 20,000 | 16,000 | 6,000 | 16,000 | 22,000 |
| TOTAL | $6,088,000 | $5,930,000 | $6,272,000 | $6,450,000 | $6,415,000 |
| Total Liabilities And Equity | $12,794,000 | $12,837,000 | $13,223,000 | $13,312,000 | $13,442,000 |